Related Experiment Videos
MPP+ produces progressive neuronal degeneration which is mediated by oxidative stress
J Fallon1, R T Matthews, B T Hyman
1Alzheimer's Disease Research Unit, Massachusetts General Hospital, Boston, USA.
Abstract:
The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which produces Parkinsonism, is mediated by its metabolite 1-methyl-4-phenylpyridinium ion (MPP+). When injected into the striatum MPP+ is accumulated by dopaminergic nerve terminals and is then retrogradely transported to the substantia nigra compacta. The mechanism by which it mediates cell death involves both inhibition of complex I of the electron transport chain and free radical generation. In the present experiments we found that administration of the free radical spin trap N-tert-butyl-alpha-(2-sulfophenyl) nitrone (S-PBN) significantly attenuated substantia nigra cell loss produced by MPP+ administration into rat striatum. We also found that coadministration of coenzyme Q10 with nicotinamide, which attenuates energy depletion, significantly blocked MPP(+)-induced substantia nigra damage. Last, we found that a single administration of MPP+ into rat striatum can produce progressive cell loss in the substantia nigra and that administration of S-PBN starting 7 days after administration of MPP+ can block the ensuing neuronal damage. These observations suggest that a one-time exposure to a neurotoxic agent may result in progressive neuronal degeneration mediated by oxidative stress.
Insights
The neurotoxin MPP+ causes Parkinsonism by damaging substantia nigra neurons through oxidative stress. Spin traps like S-PBN can block this progressive cell loss, offering potential therapeutic strategies.
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) induces Parkinsonism via its metabolite MPP+.
- MPP+ targets dopaminergic neurons in the substantia nigra, leading to cell death.
- MPP+-induced neurotoxicity involves mitochondrial complex I inhibition and free radical generation.
Purpose of the Study:
- To investigate the neuroprotective effects of the free radical spin trap S-PBN against MPP+-induced neurotoxicity.
- To evaluate the efficacy of interventions targeting energy depletion (coenzyme Q10 and nicotinamide) in preventing MPP+-induced damage.
- To determine if delayed administration of S-PBN can mitigate progressive substantia nigra cell loss.
Main Methods:
- MPP+ was administered into the striatum of rats.
- Rats were treated with the spin trap S-PBN, coenzyme Q10 with nicotinamide, or S-PBN at delayed intervals.
- Substantia nigra cell loss was assessed to evaluate neuroprotection.
Main Results:
- S-PBN administration significantly attenuated MPP+-induced substantia nigra cell loss.
- Coadministration of coenzyme Q10 and nicotinamide blocked MPP+-induced substantia nigra damage.
- Delayed administration of S-PBN, initiated 7 days after MPP+ exposure, prevented progressive neuronal degeneration.
Conclusions:
- Oxidative stress plays a critical role in the progressive neurodegeneration induced by MPP+.
- Targeting free radical generation and energy depletion shows promise in mitigating Parkinsonian neurotoxicity.
- A single exposure to neurotoxins can initiate a cascade of progressive neuronal damage, potentially treatable even after a delay.